drugset / Trial / NCT05663242

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

NCT05663242

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary early lung cancer. The study will enroll approximately 300 volunteers to compare the progression-free or overall survival in patients undergoing video-assisted thoracoscopic surgery (VATS) for primary lung tumors between propofol and sevoflurane for the maintenance of anesthesia.

Timeline

Start
2022-12-27
Primary completion
2026-11-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 2 ug/ml Intravenous
Subject Propofol Small molecule 4 ug/ml Intravenous
Subject Sevoflurane Other / unclassified 1 % Inhaled
Subject Sevoflurane Other / unclassified 3 % Inhaled

Indications